Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-024056
Filing Date
2024-02-05
Accepted
2024-02-05 16:07:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10039
  Complete submission text file 0001193125-24-024056.txt   11013
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)